Patient's Whole Process Follow-up Management(HOPE-1)
Recruiting · NCT05339568 · Observational (researchers observe without assigning treatment) · Lead sponsor: Qianfoshan Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Patients' whole process follow-up and management platform
What this trial is about
Our project is going to explore whether management and follow-up of locally advanced/metastatic patients using the patient process management platform can prolong patient survival and improve patient quality of life.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Fully understand the research and voluntarily sign the informed consent form (ICF)
- Male or female subjects who are over 18 years old (inclusive) at the time of signing the informed consent form.
- The subject is diagnosed pathologically or cytologically with non-small cell lung cancer(NSCLC).
- According to the 8th edition of the American Joint Committee on Cancer \[AJCC\], it is classified as stage IIB, stage III, stage IV NSCLC.
- Not suitable for radical treatment or refuse surgery.
- The life expectancy is not less than 3 months.
- Be able to use a smartphone.
Exclusion criteria
- Patients with mental illness.
- Presence of any other malignant tumor.
- Patients who are expected to undergo radical surgery.
- Currently participating in clinical trials.
- Subjects who judged by the investigator to be unsuitable to participate in the trial.
Where it is running
1 location listed.
- The First Affiliated Hospital of Shandong First Medical University - Jinan, Shandong, China